Clinical Trial Update: Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial protocol evaluating pneumonitis prevention using pentoxifylline and alpha-tocopherol in stage III non-small cell lung cancer patients und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alpha-tocopherol (alpha-tocopherol)
• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non-Small Cell Lung Cancer, Radiation Induced Lung Injury (RILI) | Phase 2 | Status: NOT_YET_RECRUITING